BALDWIN BROTHERS LLC/MA - IMMUNIC INC ownership

IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 56 filers reported holding IMMUNIC INC in Q3 2023. The put-call ratio across all filers is 15.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALDWIN BROTHERS LLC/MA ownership history of IMMUNIC INC
ValueSharesWeighting
Q3 2022$3,0000.0%1,0000.0%0.00%
Q2 2022$3,000
-72.7%
1,0000.0%0.00%
-100.0%
Q1 2022$11,000
+10.0%
1,0000.0%0.00%0.0%
Q4 2021$10,000
+11.1%
1,0000.0%0.00%0.0%
Q3 2021$9,000
-25.0%
1,0000.0%0.00%0.0%
Q2 2021$12,000
-25.0%
1,0000.0%0.00%
-50.0%
Q1 2021$16,000
+6.7%
1,0000.0%0.00%0.0%
Q4 2020$15,000
-21.1%
1,0000.0%0.00%
-33.3%
Q3 2020$19,0001,0000.00%
Other shareholders
IMMUNIC INC shareholders Q3 2023
NameSharesValueWeighting ↓
AWH Capital, L.P. 1,000,000$1,400,0000.88%
Omega Fund Management, LLC 1,788,160$2,503,4240.84%
COMMODORE CAPITAL LP 1,800,000$2,5200.38%
Ikarian Capital, LLC 650,000$910,0000.22%
Gratus Capital, LLC 1,668,294$2,335,6120.19%
GREAT POINT PARTNERS LLC 632,184$885,0580.17%
Parkman Healthcare Partners LLC 459,770$643,6780.17%
Anson Funds Management LP 664,935$930,9090.15%
SILVERARC CAPITAL MANAGEMENT, LLC 350,656$490,9180.14%
COWEN AND COMPANY, LLC 791,024$1,107,4330.12%
View complete list of IMMUNIC INC shareholders